Acute chorea associated with metoclopramide use

American Journal of Therapeutics

Volumn 13, Issue 6, 2006, Pages 543-544

  Dubow, Jordan S ^a   Leikin, Jerrold ^b   Rezak, Michael ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Glenbrook Hospital   (United States)

Author keywords

Chorea; Drug induced dyskinesia; Dyskinesia

Indexed keywords

DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; QUETIAPINE;

ADULT; AKATHISIA; ARTICLE; CASE REPORT; CHEMOTHERAPY INDUCED EMESIS; CHOREA MINOR; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPERKINESIA; MIGRAINE; MULTIPLE MYELOMA; NAUSEA; PARKINSONISM; PRIORITY JOURNAL; STOMACH PARESIS; TARDIVE DYSKINESIA;

ACUTE DISEASE; ADULT; CHOREA; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; METOCLOPRAMIDE;

EID: 33751377071     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000208271.34755.5b     Document Type: Article

References (9)

1. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Arch Intern Med. 1989;149:2486-2492.
2. Ganzinil, Casey DE, Hoffman WF, Mccall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469-1475.
3. Metoclopramide package insert. Gensiasicor Pharmaceuticals. 2002.
4. Patterson JF. Choreiform movement associated with metoclopramide. Southern Med J. 1986;79:1465.
5. Tani T, Piao YS, Mori S, et al. Chorea resulting from paraneoplastic striatal encephalitis. J Neurol Neurosurg Psychiatry. 2000;69:512-515.
6. Nuti A, Ceravolo R, Salvetti S, et al. Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Movement Disord. 2000;15:350-351.
7. Kinirons P, Fulton A, Keoghan M, et al. Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody. Neurology. 2003;61:1623-1624.
8. Christensen RC, Byerly MJ. Mandibular dystonia associated with the cominbation of sertaline and metoclopramide. J Clin Psychiatry. 1996;57:12.
9. Wilks J. Mandibular dystonia with Zoloft and Maxolon. Aust Pharm. 1998;17:721.